文献速递关节外科

初次全髋与全膝关节置换术中抗生素预防用药特征及手术部位感染风险

Characteristics of Antibiotic Prophylaxis and Risk of Surgical Site Infections in Primary Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-04-18

该回顾性队列研究利用Premier医疗数据库(2006-2016)436,724例全髋关节置换(THA)和862,918例全膝关节置换(TKA)数据,分析抗生素预防方案与术后30天内手术部位感染(SSI)的关系。结果显示,与头孢唑林相比,万古霉素等非头孢唑林方案与SSI风险增加相关,而预防用药持续至术后第1天并未改变SSI风险。

要点

  • THA中SSI发生率为0.21%,TKA中为0.22%。
  • 与头孢唑林相比,THA中万古霉素与SSI风险增加相关(OR=1.36)。
  • TKA中万古霉素、万古霉素+头孢唑林、克林霉素及其他组合均与SSI风险增加相关。

核心结论

  • 在全髋和全膝关节置换患者中,非头孢唑林的抗生素预防方案与手术部位感染风险增加相关。

研究设计与样本

  • 回顾性队列研究,使用Premier Healthcare Database(2006-2016)数据,纳入436,724例THA和862,918例TKA。

主要发现

  • THA的SSI患病率为0.21%(n=914),TKA为0.22%(n=1914)。
  • THA中最常用抗生素为头孢唑林(74.1%)、万古霉素(8.4%)、其他抗生素组合(7.1%)、万古霉素+头孢唑林(5.1%)、克林霉素(3.3%)。
  • 51.8%的THA患者仅在手术当天(第0天)接受预防用药,48.2%持续至术后第1天;TKA模式类似。
  • 与头孢唑林相比,THA中万古霉素的SSI比值比(OR)为1.36(95%CI 1.09-1.71)。
  • TKA中与头孢唑林相比,万古霉素OR=1.29(95%CI 1.10-1.52),万古霉素+头孢唑林OR=1.35(95%CI 1.12-1.64),克林霉素OR=1.38(95%CI 1.11-1.71),其他抗生素组合OR=1.28(95%CI 1.07-1.53)。

关键数值与推荐

  • 预防用药持续时间(仅第0天 vs 至第1天)未改变SSI的比值比。

临床怎么用

  • 针对THA/TKA患者,选择头孢唑林作为预防用药可能有助于降低SSI风险;非头孢唑林方案与SSI风险增加相关。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite numerous antibiotic prophylaxis options for total hip arthroplasty (THA) and total knee arthroplasty (TKA), an assessment of practice patterns and comparative effectiveness is lacking. We aimed to characterize antibiotic utilization patterns and associations with infection risk and hypothesized differences in infection risk based on regimen. METHODS: A retrospective cohort study was performed using data from 436,724 THA and 862,918 TKA (Premier Healthcare Database; 2006-2016). Main exposures were antibiotic type and duration: day of surgery only (day 0) or through postoperative day 1 (day 1). The primary outcome was surgical site infection (SSI) <30 days postoperation. Mixed-effect models measured associations between prophylaxis regimen and SSI as odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: SSI prevalence was 0.21% (n = 914) for THA and 0.22% (n = 1914) for TKA. Among THA procedures, the most commonly used antibiotics were cefazolin (74.1%), vancomycin (8.4%), "other" antibiotic combinations (7.1%), vancomycin + cefazolin (5.1%), and clindamycin (3.3%). Here, 51.8% received prophylaxis on day 0 only, whereas 48.2% received prophylaxis through day 1. Similar patterns existed for TKA. Relative to cefazolin, higher SSI odds were seen with vancomycin (OR = 1.36; CI 1.09-1.71) in THA and with vancomycin (OR = 1.29; CI = 1.10-1.52), vancomycin + cefazolin (OR = 1.35; CI = 1.12-1.64), clindamycin (OR = 1.38; CI = 1.11-1.71), and "other" antibiotic combinations (OR = 1.28; CI = 1.07-1.53) in TKA. Prophylaxis duration did not alter SSI odds. Results were corroborated in sensitivity analyses. CONCLUSION: Antibiotic prophylaxis regimens other than cefazolin were associated with increased SSI risk among THA/TKA patients. These findings emphasize a modifiable intervention to mitigate infection risk.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zastrow RK, Huang HH, Galatz LM, et al. Characteristics of Antibiotic Prophylaxis and Risk of Surgical Site Infections in Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32402578. doi:10.1016/j.arth.2020.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。